EPO and amyotrophic lateral sclerosis: However, consistent with our findings, EPO levels in the cerebrospinal fluid (CSF) of patients with ALS have been reported to be reduced compared to those in patients with Alzheimer’s disease and individuals with tension-type headache serving as controls.